Heng Guan

433 total citations
24 papers, 322 citations indexed

About

Heng Guan is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heng Guan has authored 24 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heng Guan's work include Peripheral Artery Disease Management (7 papers), Cerebrovascular and Carotid Artery Diseases (6 papers) and Pituitary Gland Disorders and Treatments (4 papers). Heng Guan is often cited by papers focused on Peripheral Artery Disease Management (7 papers), Cerebrovascular and Carotid Artery Diseases (6 papers) and Pituitary Gland Disorders and Treatments (4 papers). Heng Guan collaborates with scholars based in China, Oman and Thailand. Heng Guan's co-authors include Changwei Liu, Bao Liu, Xiaojun Song, Yongjun Li, Yuehong Zheng, Sarwono Waspadji, Qi Miao, Zhi Min Liu, Stephen W.K. Cheng and Young Seol Kim and has published in prestigious journals such as PLoS ONE, Journal of Vascular Surgery and Molecular and Cellular Endocrinology.

In The Last Decade

Heng Guan

24 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Guan China 11 150 90 89 55 51 24 322
Claudio Vincenzoni Italy 9 96 0.6× 59 0.7× 97 1.1× 67 1.2× 62 1.2× 24 291
T. Musella Italy 10 52 0.3× 169 1.9× 23 0.3× 63 1.1× 7 0.1× 14 388
Ching‐Chia Li Taiwan 13 159 1.1× 49 0.5× 139 1.6× 6 0.1× 27 0.5× 30 376
Ruo H. Song United States 8 124 0.8× 24 0.3× 77 0.9× 79 1.4× 5 0.1× 9 373
Jee Won Park South Korea 13 165 1.1× 151 1.7× 94 1.1× 32 0.6× 4 0.1× 33 478
Ishran M. Saadiq United States 13 131 0.9× 10 0.1× 87 1.0× 55 1.0× 16 0.3× 32 469
Frank Kramer Germany 15 99 0.7× 55 0.6× 68 0.8× 352 6.4× 4 0.1× 27 583
Virginia Álvarez Spain 17 129 0.9× 49 0.5× 74 0.8× 241 4.4× 3 0.1× 41 505
Xiaohua Zhang China 11 189 1.3× 17 0.2× 50 0.6× 32 0.6× 15 0.3× 24 331
Eisuke Hamaguchi Japan 13 312 2.1× 34 0.4× 103 1.2× 74 1.3× 12 0.2× 25 636

Countries citing papers authored by Heng Guan

Since Specialization
Citations

This map shows the geographic impact of Heng Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Guan more than expected).

Fields of papers citing papers by Heng Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Guan. The network helps show where Heng Guan may publish in the future.

Co-authorship network of co-authors of Heng Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Guan. A scholar is included among the top collaborators of Heng Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Guan. Heng Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yan, et al.. (2024). The mechanism of 14-3-3η in thyroxine induced mitophagy in cardiomyocytes. Molecular and Cellular Endocrinology. 590. 112271–112271. 3 indexed citations
2.
Ji, Lei, Zhili Liu, Fangda Li, et al.. (2021). Proposed modification to the Shamblin's classification of carotid body tumors: A single-center retrospective experience of 116 tumors. European Journal of Surgical Oncology. 47(8). 1953–1960. 16 indexed citations
3.
Wang, Yi, Bao Liu, Yu Chen, et al.. (2019). Distinct features of malignant carotid body tumors and surgical techniques for challengeable lesions: a case series of 11 patients. European Archives of Oto-Rhino-Laryngology. 277(3). 853–861. 15 indexed citations
4.
Liu, Changwei, Heng Guan, Yuehong Zheng, et al.. (2014). [Diagnostic and therapeutic analysis of malignant carotid body tumors].. PubMed. 94(11). 828–31. 1 indexed citations
5.
Wang, Ou, Chunyan Wang, Min Nie, et al.. (2012). Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas. PLoS ONE. 7(9). e45567–e45567. 42 indexed citations
6.
Liu, Wei, et al.. (2012). Zinc Finger Protein-activating Transcription Factor Up-regulates Vascular Endothelial Growth Factor-A Expression in Vitro. Chinese Medical Sciences Journal. 27(3). 171–175. 2 indexed citations
7.
Liu, Changwei, et al.. (2011). Efficacy of Surgical Therapy for Carotid Body Tumors. Chinese Medical Sciences Journal. 26(4). 241–245. 16 indexed citations
8.
Liu, Changwei, Yuehong Zheng, Jiang Shao, et al.. (2010). Surgical Resection of the Inferior Vena Cava for Leiomyosarcoma. Annals of Vascular Surgery. 24(6). 822.e11–822.e15. 14 indexed citations
9.
Ni, Leng, Changwei Liu, Bao Liu, et al.. (2010). [Diagnosis and treatment of 193 cases under 45 years old with peripheral arterial disease].. PubMed. 48(1). 15–8. 1 indexed citations
10.
Liu, Bao, Changwei Liu, Heng Guan, et al.. (2009). Intravenous leiomyomatosis with inferior vena cava and heart extension. Journal of Vascular Surgery. 50(4). 897–902. 56 indexed citations
11.
Guan, Heng, et al.. (2009). Reinstate the Damaged VEGF Signaling Pathway with VEGF-activating Transcription Factor. Chinese Medical Sciences Journal. 24(3). 186–190. 1 indexed citations
12.
Guan, Heng, et al.. (2009). Myoglobin over-expression attenuates angiogenic response in hindlimb ischemia in mice.. PubMed. 122(9). 1056–60. 3 indexed citations
13.
Guan, Heng. (2008). Effect of CYP2C9 Genetic Polymorphisms on Warfarin Dosage and Anticoagulation. Zhōnghuá yàoxué zázhì. 1 indexed citations
14.
Yang, Jing, et al.. (2008). Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis. European Journal of Pharmaceutical Sciences. 35(5). 427–434. 23 indexed citations
15.
Liu, Bao, et al.. (2008). [Experience in management of intravenous leiomyomatosis with inferior vena cava extension].. PubMed. 88(3). 153–7. 3 indexed citations
16.
Guan, Heng, Zhimin Liu, Xiaohui Guo, et al.. (2007). [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].. PubMed. 87(1). 23–7. 8 indexed citations
17.
Guan, Heng, Yongjun Li, Zhangrong Xu, et al.. (2007). Prevalence and risk factors of peripheral arterial disease in diabetic patients over 50 years old in China.. PubMed. 22(2). 83–8. 11 indexed citations
18.
Rhee, Sang Youl, Heng Guan, Zhi Min Liu, et al.. (2006). Multi-country study on the prevalence and clinical features of peripheral arterial disease in asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Research and Clinical Practice. 76(1). 82–92. 68 indexed citations
19.
Guan, Heng, et al.. (2002). Surgical management of Ehlers-Danlos syndrome: first report of a pedigree in China.. PubMed. 17(3). 178–82. 3 indexed citations
20.
Guan, Heng, et al.. (2002). Nanoparticle as a new gene transferring vector in specific expression gene.. PubMed. 17(4). 220–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026